FOSTER CITY, Calif., Jan. 25, 2017 -- QuinStreet, Inc. (Nasdaq:QNST), the leader in performance marketing products and technologies, today announced it will report financial results for the second quarter ended December 31, 2016 following the close of market on Wednesday, February 8, 2017. On that day, management will hold a conference call and webcast at 2:00 pm PT to review and discuss the company's results.
| What: | QuinStreet Second Quarter Fiscal Year 2017 Earnings Results Conference Call | |||
| When: | Wednesday, February 8, 2017 | |||
| Time: | 2:00 PM PT | |||
| Dial in: | +1 (888) 765.5576 (domestic) +1 (913) 312.1516 (international) | |||
| Replay Instructions: | To access the replay, please register online at https://jsp.premiereglobal.com/webrsvp and use confirmation 6404615 to obtain dial-in information. Dial-in information for the replay will be available beginning one day prior to the conference call. | |||
| Webcast URL: | http://investor.quinstreet.com/ |
About QuinStreet
QuinStreet, Inc. (Nasdaq:QNST) is one of the largest Internet performance marketing and media companies in the world. QuinStreet is committed to providing consumers and businesses with the information they need to research, find and select the products, services and brands that meet their needs. For more information, please visit www.QuinStreet.com.
Investor Contact: Erica Abrams (415) 297-5864 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



